ArticleAccounts of chemical research2025
Glycome-Proteome Interactome Cartography via Proximity Tagging.
Article in Accounts of chemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Glycans are now recognized as essential biomolecules for life, and an increasing number of investigators and studies continue to reveal the myriad ways in which these post-translational modifications regulate important biological events. Chief among the ways in which glycans carry out their roles is by engaging in binding interactions with glycan-binding proteins (GBPs). Such interactions are important for proper physiology or in the activation of disease. Thus, achieving a precise molecular understanding of these interactions can pave new avenues for synthetic control and potentially therapeutic strategies to regulate disease. In this Account, we discuss our efforts toward revealing the collective interactions between glycans, protein glycoconjugates, and GBPs in cells, with an eye toward identifying the specific glycan-carrying proteins that interact with the GBPs in a functional manner.While the importance of studying glycan-GBP interactions has long been established, prior to our work, much of glycoscience had been occupied with the systematic assignment of the structural features of glycans required for recognition by GBPs in vitro, often using homogeneous glycan arrays. This important body of work enabled the preliminary identification of principal GBP-glycan binding preferences and allowed the rational design of functionalized glycan molecules to use as competitive inhibitors. Equipped with these two sets of important tools, expanding our understanding of glycan-GBP interactions from in vitro glycan binding preferences toward that of glycoprotein-GBP interactions
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.